deltatrials
Completed PHASE3 INTERVENTIONAL 4-arm NCT04534725

COVID-19 Prevention and Treatment in Cancer; a Sequential Multiple Assignment Randomised Trial; (C-SMART)

COVID-19 Prevention and Treatment in Cancer; a Sequential Multiple Assignment Randomised Trial; C-SMART Study.

Sponsor: Peter MacCallum Cancer Centre, Australia

Conditions Cancer Covid19 Respiratory Viral Infection
Interventions Interferon alfa Lenzilumab Selinexor
Updated 8 times since 2020 Last updated: Aug 23, 2023 Started: Dec 17, 2020 Primary completion: Nov 28, 2022 Completion: Apr 19, 2023
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE3 trial investigates Cancer and Covid19 and is currently completed. Peter MacCallum Cancer Centre, Australia leads this study, which shows 8 recorded versions since 2020 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

~Oct 2020 – ~Nov 2020 · 31 days · monthly snapshotNot Yet Recruiting~Nov 2020 – ~Jan 2021 · 2 months · monthly snapshotNot Yet Recruiting~Jan 2021 – ~Feb 2021 · 31 days · monthly snapshotRecruiting~Feb 2021 – ~Sep 2021 · 7 months · monthly snapshotRecruiting~Sep 2021 – ~Sep 2023 · 24 months · monthly snapshotRecruiting~Sep 2023 – ~Jul 2024 · 10 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – present · 23 months · monthly snapshotCompleted

Change History

8 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed PHASE3

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE3

  3. Sep 2023 — Jul 2024 [monthly]

    Completed PHASE3

    Status: Recruiting → Completed

  4. Sep 2021 — Sep 2023 [monthly]

    Recruiting PHASE3

  5. Feb 2021 — Sep 2021 [monthly]

    Recruiting PHASE3

▶ Show 3 earlier versions

  1. Jan 2021 — Feb 2021 [monthly]

    Recruiting PHASE3

    Status: Not Yet Recruiting → Recruiting

  2. Nov 2020 — Jan 2021 [monthly]

    Not Yet Recruiting PHASE3

  3. Oct 2020 — Nov 2020 [monthly]

    Not Yet Recruiting PHASE3

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Peter MacCallum Cancer Centre, Australia
Data source: Peter MacCallum Cancer Centre, Australia

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations